Search results

NG59/7 Question What is the clinical and cost effectiveness of opioids for the management of acute sciatica? Any explanatory notes(if...

Result type

Research recommendation

Published

26 October 2020

This guideline covers the clinical care of adults (18 years and over) who are dying during the last 2 to 3 days of life. It aims to improve end of life care for people in their last days of life by communicating respectfully and involving them, and the people important to them, in decisions and by maintaining their comfort and dignity. The guideline covers how to manage common symptoms without causing unacceptable side effects and maintain hydration in the last days of life.

Result type

NICE guideline

Published

16 December 2015

are needed by family members or carers of people having treatment with an opioid, benzodiazepine, Z‑drug, antidepressant or...

Result type

Research recommendation

Published

11 May 2022

cost-effective methods of addressing patient and carer concerns about strong opioids, including anticipating and managing adverse...

Result type

Research recommendation

Published

9 June 2015

Discontinued Reference number: GID-TAG367

Result type

Technology appraisal guidance

Status

Discontinued

This guideline covers recognition, referral, investigation and management of spinal metastases and metastatic spinal cord compression (MSCC). It is also relevant for direct malignant infiltration of the spine and associated cord compression. It aims to improve early diagnosis and treatment to prevent neurological injury and improve prognosis.

Result type

NICE guideline

Published

6 September 2023

multicomponent intervention to support dose reduction during withdrawal of opioids? Any explanatory notes(if applicable) For a short...

Result type

Research recommendation

Published

11 May 2022

gabapentinoids) should not be used for sciatica. There was no evidence on the use of opioids for sciatica. Given the lack of evidence...

Result type

Research recommendation

Published

26 October 2020

This guideline covers managing neuropathic pain (nerve pain) with pharmacological treatments (drugs) in adults in non-specialist settings. It aims to improve quality of life for people with conditions such as neuralgia, shingles and diabetic neuropathy by reducing pain and promoting increased participation in all aspects of daily living. The guideline sets out how drug treatments for neuropathic pain differ from traditional pain management.

Result type

Clinical guideline

Last updated

22 September 2020

Evidence-based recommendations on percutaneous electrical nerve stimulation for refractory neuropathic pain. This involves inserting electrode needles underneath the skin connected to a stimulator device.

Result type

HealthTech guidance

Published

27 March 2013

Evidence-based recommendations on nalmefene (Selincro) for reducing alcohol consumption in adults with alcohol dependence.

Result type

Technology appraisal guidance

Published

26 November 2014

Evidence-based recommendations on laparoscopic cystectomy. This involves removing the bladder using small cuts in the abdomen (keyhole surgery).

Result type

HealthTech guidance

Published

25 February 2009

Evidence-based recommendations on laparoscopic renal denervation for loin pain haematuria syndrome in adults. This involves the stripping away of nerves from the kidney using keyhole surgery to relieve pain.

Result type

HealthTech guidance

Published

27 October 2021

Subscribe to NICE newsletters and alerts for the latest healthcare guidance, clinical updates, and evidence-based resources across health and social care.

Evidence-based recommendations on transcranial MRI-guided focused ultrasound thalamotomy for neuropathic pain in adults. This involves delivering focused ultrasound to a small part of the brain (in the thalamus) responsible for transmitting pain signals to destroy it.

Result type

HealthTech guidance

Published

28 November 2018